Evofem Biosciences Company Description

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health.

Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.

Evofem Biosciences, Inc. is headquartered in San Diego, California.

Evofem Biosciences, Inc.

Country	United States
Industry	Biotechnology
Sector	Healthcare
Employees	32
CEO	Saundra Pelletier

Contact Details

Address: 7770 Regents Roas San Diego, Delaware 92122 United States
Phone	858 550 1900
Website	evofem.com

Stock Details

Ticker Symbol	EVFM
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US30048L2034
SIC Code	2834

Key Executives

Name	Position
Saundra Pelletier	Interim Chair, President and Chief Executive Officer
Ivy Zhang CPA	Chief Financial Officer and Secretary
Ellen Thomas	Chief of Staff
Amy Raskopf	Chief Business Development Officer
Kathy Gallo-Doyle	Senior Vice President of Commercial Operations